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https://doi.org/10.1016/j.stemcr.2019.10.010SUMMARYCell lineage reprogramming via transgene overexpression of keymaster regulatory transcription factors has beenwell documented. How-
ever, the poor efficiency and lack of fidelity of this approach is problematic. Synthetic transcription factors (sTFs)—built from the repur-
posed CRISPR/Cas9 system—can activate endogenous target genes to direct differentiation or trigger lineage reprogramming. Here we
explored whether sTFs could be used to steer mouse neural stem cells andmouse embryonic fibroblasts toward the oligodendrocyte line-
age. We developed a non-viral modular expression system to enable stable multiplex delivery of pools of sTFs capable of transcriptional
activation of three key oligodendrocyte lineage master regulatory genes (Sox10, Olig2, andNkx6-2). Delivery of these sTFs could enhance
neural stem cell differentiation and initiated mouse embryonic fibroblast direct reprograming toward oligodendrocyte progenitor-like
cells. Our findings demonstrate the value of sTFs as tools for activating endogenous genes and directing mammalian cell-type identity.INTRODUCTION
New opportunities to directly manipulate endogenous
gene expression in mammalian cells have emerged from
the fields of genome editing and synthetic biology,
including: synthetic transcription factors (sTFs) or chro-
matin editors, as well as improved DNA synthesis, assem-
bly, and delivery methods. sTFs are engineered chimeric
proteins containing a DNA-binding domain fused to tran-
scriptional or chromatin regulatory effector domains.
sTFs were pioneered using zinc-finger transcription factors
(reviewed in Keung et al. [2015]). CRISPR/Cas9 has
emerged as a preferred platform for manufacture of sTFs
(Gilbert et al., 2013). Catalytically dead Cas9 (dCas9)—a
nuclease-deficient variant of Cas9 endonuclease—retains
site-specific binding but lacks DNA cutting activity.
dCas9, therefore, still binds via the complementarity of a
short guide RNA (sgRNA) to predetermined target DNA
sequence yet does not cleave the DNA. When tethered to
transcriptional activation domains, such as VP160, the re-
sulting programmable dCas9-based sTF is able to activate
target gene transcription (Perez-Pinera et al., 2013; Cheng
et al., 2013). sTFs based on the dCas9 architecture can
therefore be used to drive cell lineage programming or dif-
ferentiation via activation of endogenous master regulato-
ry transcription factors.
Several recent examples of sTF-directed control of
mammalian cell differentiation have been described for
pluripotent cell differentiation (embryonic stem cells
[ESCs] or induced pluripotent stem cells [iPSCs]) including
neurons, trophoblast stem cells, or pancreatic lineages
(Balboa et al., 2015; Chavez et al., 2015). sTFs have alsoStem C
This is an open access article under the Cbeen used to drive lineage conversions by targeting a single
master regulator, e.g., activation ofMyoD to drive fibroblast
reprogramming to skeletal myocytes (Chakraborty et al.,
2014); and, recently, remodeling of the Sox2 locus to trigger
reprogramming of fibroblasts to iPSCs (Liu et al., 2018).
Multiplex gene activation is more challenging. However,
Black et al. (2016) demonstrated successful direct lineage
conversion of fibroblasts to neurons by simultaneous sTF-
based activation of Ascl1, Pou3f2, andMyt1l using cocktails
of lentiviral vectors.
Despite these successes, important barriers remain. More
efficient strategies are needed to build plasmids containing
multiple sTFs. This remains challenging due to repetitive
sequences inherent to sgRNA structure. It also remains
challenging to stably deliver cocktails of multiple sTFs. At
present, only lentiviral systems, with their inherent limita-
tions in cargo size, or Gateway cloning-based systems—
which have a low number of unique cloning sites—have
been used to construct sTFs targeting multiple genes for
cell lineage programming. Each of these approaches has re-
strictions for multiplexing. It is also uncertain whether
multiplex activation and direct lineage reprogramming
with sTFs will be robust and reliable for lineage conversions
other than fibroblasts to neurons (Black et al., 2016).
One clinically important cell type is the oligodendrocyte
(OL), which is disrupted in demyelinating diseases
(Franklin and Ffrench-Constant, 2017). OLs and their
oligodendrocyte progenitor cell (OPC) are potentially
attractive targets for cell-based therapies and disease
modeling, as their functional properties are less diverse
and region/subtype specific than neurons. Differentiation
of human iPSCs toOLs has been achieved andhas providedell Reports j Vol. 13 j 1–15 j December 10, 2019 j ª 2019 The Authors. 1
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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after transplantation (Goldman, 2016). Also, direct lineage
conversion of fibroblasts to generate OPCs has been
demonstrated by viral overexpression of OLIG2, SOX10,
and NKX6-2 (Najm et al., 2013), providing a more direct
route to OL production ex vivo.
Here we tested whether sTFs can be used to facilitate cell
fate programming toward OLs in neural stem cells (NSCs)
and mouse embryonic fibroblasts (MEFs). We developed
an improved modular cloning strategy to facilitate con-
struction of single plasmids that can carry up to eight
gRNAs plus dCas9-VP160 and delivered these efficiently
and stably into primaryNSCs or fibroblasts using a transpo-
sase-based approach. We show that sTF-based activation of
Sox10 in NSCs will trigger specification to OPCs and OLs.
Furthermore, we also demonstrate that fibroblast reprog-
ramming to MBP-expressing OL-like cells can be achieved
by sTF-based activation of three major OL lineage regula-
tors: Sox10, Olig2, and Nkx6-2.RESULTS
Activation of Endogenous Sox10 in Mouse NSCs Using
dCas9/sgRNAs
Sox10 is a known regulator of OL specification and differen-
tiation in development, differentiating PSCs, and cultured
NSCs (Garcı´a-Leo´n et al., 2018; Stolt et al., 2006; Wang
et al., 2013). We first explored whether dCas9-VP160 canFigure 1. Activation of Endogenous Sox10 Transcription in Neural
(A) Schematic representation of the sgRNA target positions designe
proximal Sox10 promoter (400 to 50 bp from TSS) were tested (te
(B and C) qRT-PCR results for Sox10 mRNA in NSCs (PDGFRa-GFP report
and dCas9-VP160. (B) Single co-transfected gRNAs (A, B, C, etc.) comp
ANOVA p = 0.0004). (C) Comparison of pools of three most active and
Negative control is cells transfected with dCas9-VP160 alone (No gRN
(D) Schematic of ‘‘S3’’ plasmid containing 3 3 gRNAs targeting Sox10
arms for stable integration into the genome of PG1.1 cells (PG1.1-S3
(E) qRT-PCR for Sox10 mRNA in PG1.1-S3 cells in self-renewal conditio
p = 0.04).
(F and G) Graphical representation of experimental design. Parenta
(1.3 3 104 cell/cm2) on day 0 to minimize spontaneous differentiati
conditions (EGF and FGF) and checked for PDGFRa-GFP using flow cytom
removal of EGF and addition of PDGF-AA and Forskolin. Four days afte
flow cytometry.
(H and I) Typical example of flow cytometry at day 5 for PDGFRa-GFP
grown under (H) self-renewal conditions or (I) differentiation condit
(J and K) Quantification of flow cytometry data, either in (J) self-ren
differentiation conditions (n = 3; unpaired t test p < 0.0001).
(L) qRT-PCR data for Pdgfra, Ng2, and Olig2 mRNA in PG1.1 S3 NSC (‘
differentiated parental PG1.1 cells (n = 3).
Statistical analysis—dots represent biological replicates, bars indica
Statistical significance is marked by asterisks (*). See also Figures S1activate Sox10 transcription in mouse NSCs, and whether
this influenced their subsequent differentiation into OLs.
We screened 10 individual gRNAs located 450
to 50 bp upstream of Sox10 transcription start site (TSS)
(Figure 1A). Targeting this region was previously shown
to generatemost functional gRNAs (Gilbert et al., 2014). In-
dividual or pools of gRNAs were co-transfected with dCas9-
VP160 in NSCs (Figure 1B). Three gRNAs were identified
that could increase levels of Sox10 mRNA by 10-fold
when delivered individually (G, H, and I). However, we
found that co-transfection of a pool of all 10 gRNAs (A–J)
gave >217-fold increase in mRNA (Figure 1B). A synergistic
effect was also seen when co-transfecting a pool of the
three individually most potent gRNAs together with
dCas9-VP160 (G–I) (Figure 1C). This is consistent with find-
ings from previous reports that showed co-delivery of mul-
tiple gRNAs can significantly increase transcription of the
target gene, likely via some synergistic effect (Black et al.,
2016; Perez-Pinera et al., 2013). Concomitant delivery of
multiple sTFsmay, therefore, provide themost robust strat-
egy to activate target gene expression. Furthermore, tran-
scription activation and overexpression of the target gene
with dCas9-VP160 is a transient phenomenon as almost
no Sox10 mRNA could be detected 12 days after transfec-
tion (Figure S2G).
Targeting of multiple ‘‘master regulators’’ would likely be
required for sTFs to be effective in direct reprogramming.
Next, we designed a plasmid-based expression system
that could enable simultaneous delivery of gRNAs againstStem Cells and Specification to Oligodendrocyte Precursor Cells
d for transcriptional activation of Sox10. Ten gRNAs spanning the
rmed A through to J).
er cells; termed PG1.1) 3 days after the co-transfection with gRNAs
ared with a pool of 10 co-transfected gRNAs (n = 2; ordinary one-way
three inactive gRNAs (n = 2; ordinary one-way ANOVA p = 0.007).
As).
, CAG-driven mRuby for selection and dCas9-VP160 with PiggyBac
).
ns (EGF plus FGF-2) 3 weeks after integration (n = 3; unpaired t test
l and sTF-containing PG1.1 NSCs were seeded at medium density
on arising from high confluence. (F) Cells were left in self-renewal
etry every day until day 5. (G) Cells were induced to differentiate by
r differentiation induction, cells were scored for PDGFRa-GFP using
in PG1.1 (‘‘Parental’’), PG1.1 S (‘‘cDNA’’), and PG1.1 S3 (‘‘sTF’’) NSCs
ions.
ewal conditions (n = 3; ordinary one-way ANOVA p < 0.0009) or (K)
‘sTF Sox10 3 3 gRNAs’’) 4 days after differentiation, normalized to
te means; error bar represent SD; unpaired t tests were performed.
–S3.
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vector was built containing: (1) a CAG promoter-driven
dCas9-VP160; (2) PiggyBac transposase recombination
sites (for stable genomic integration); (3) a CAG pro-
moter-driven mRuby-P2A-PuroR (for selection); and (4)
an RFP cassette that is flanked by unique BsmBI sites for
Golden Gate cloning of gRNAs (Figures 1D and S1A). Using
an adapted version of our recently described extensible
mammalian modular assembly system (Martella et al.,
2017), we designed a simple workflow that allows assembly
of multiple U6-sgRNA subunits into the A1P vector from
the single sgRNA expression plasmids (Figure S1B). To test
if recombination during plasmid preparation in bacteria
compromises plasmid integrity, we have sub-cloned,
picked, and sequenced multiple colonies. We have found
no evidence of recombination in any of the clones
(Figure S2F).
For functional validation of this design, we constructed
plasmid A1P-S3, comprising three U6-gRNAs arrays, each
with a distinct sgRNA against Sox10. This was stably inte-
grated into NSCs by co-transfection with the pBase trans-
posase (Figure 1D). Two weeks after transfection, cells
with successfully integrated plasmids (±1%) were selected
by sorting for mRuby. As expected, the resulting sTF-ex-
pressing NSCs robustly triggered increased expression of
Sox10 (Figure 1E). This A1P system can therefore be used
to deliver sTFs to precise sites in the genome for target
gene activation.
Sox10 Activation by sTFs Triggers Specification of
NSCs to OPCs and OLs
Activation of Sox10 in NSCs might bias differentiation
to OLs. Platelet-derived growth factor receptor alpha
(PDGFRa) is one of the earliest markers of OPCs. Therefore,
we generated a reporter NSC line to monitor OPC lineage
specification. An existing PDGFRa-H2B-GFP reporter trans-
genicmouse was used (Hamilton et al., 2003), andNSC cul-
tures were established from embryonic 14.5 (E14.5) fetal
forebrain (Figures S3A and S3B). We derived a clonal NSC
line from this population, termed PG1.1, which is karyo-
typically normal and displays typical NSC morphology
and markers (NESTIN, OLIG2, SOX2, and SOX9) (Fig-
ure S3C) (Conti et al., 2005). On differentiation, this
reporter line accumulated nuclear GFP when assessed by
microscopy and flow cytometry during differentiation (Fig-
ures S3D and S3E). Indeed, we find 10%–20% of cells
express GFP+ cells at day 4 of differentiation and these ex-
pressed OPC markers (Figure S3F).
To determine if Sox10 activation using sTFs can override
self-renewal signals and trigger spontaneous OPC specifica-
tion we compared sTF-induced Sox10 cells with parental
controls grown in epidermal growth factor (EGF)/fibroblast
growth factor-2 (FGF-2)-containing culture medium (non-4 Stem Cell Reports j Vol. 13 j 1–15 j December 10, 2019permissive for OPC specification). Between experiments,
cells were passaged frequently (every 2 days) and at low
confluence (<50%) to minimize spontaneous differentia-
tion. During experiments, cells were seeded at mid-range
confluence (1.3 3 104 cell/cm2) and the frequency of
PDGFRa-GFP+ cells was scored by flow cytometry every
24 h for 5 days (Figure 1F). As expected, PG1.1 parental cells
generated very few PDGFRa-GFP+ OPCs under these condi-
tions (6%GFP cells by day 5; triggered by high cell conflu-
ence at this point). By contrast, cells harboring the sTFs for
Sox10 (PG1.1 S3) induced45% of GFP+ cells by day 5 (Fig-
ures 1H and 1J).
NSCs typically differentiate into varying proportions of
astrocytes, neurons, and OLs (Conti et al., 2005), but OL
differentiation can be promoted by removal of EGF and
addition of Forskolin, FGF, and PDGF-AA to the cultureme-
dium (Figure 1G) (Glaser et al., 2007). To compare sTFs with
more traditional cDNA overexpression approaches, we
have also created a stable PG1.1 cell line that constitutively
overexpresses SOX10 and named it PG1.1-S (Figure S3G).
On differentiation in these more permissive conditions
we found that 70% of PG1.1 S3 cells (sTF-activated
Sox10 expression) and 52% of PG.1-S (cDNA overexpres-
sion of SOX10) became PDGFRa-GFP+ after 4 days of differ-
entiation (Figures 1I and 1K), whereas 15% of parental
PG1.1 NSCs were PDGFRa-GFP+. Cells containing sTFs
also had higher levels of Ng2 and Pdgfra mRNA—known
markers of OPCs (Figure 1L).We conclude that sTF-induced
expression of endogenous Sox10 primes NSCs for OPC
specification in a similar way as Sox10 cDNA overexpres-
sion (Pozniak et al., 2010).
To confirm these results in an independent NSC line and
determine if sTF-induced Sox10 could further enhance dif-
ferentiation to OLs we used wild-type early passage NSC
cultures (adult subventricular zone-derived Black6 strain
NSCs; BL6-NS). During their differentiation to OLs, OPCs
transit into post-mitotic cells that aremarked by the surface
marker O4 and are committed to OL differentiation
(Zhang, 2001). Sox10 transcriptional activation is less effi-
cient in BL6 NSCs compared with PG1.1 NSCs (data not
shown); therefore, a plasmid containing eight gRNAs (all-
in-one [Ai1]-S8) was used instead. To create a stable cell
line, BL6 cells were transfected with A1P-S8 plasmid and
pBase transposase (Figure 2A). Two weeks after transfec-
tion, cells were sorted for mRuby to select cells with inte-
grated plasmid (1.4%; Figure S2E). We found >926-fold
increase in Sox10 mRNA levels in BL6 S8 cells compared
with parental non-transfected BL6 NS control cells (Fig-
ure 2B). Protein levels of SOX10 were also confirmed using
western blot (Figure 2C). After over 20 passages, we have
genotyped our cell line to validate that it has not lost
expression cassettes due to recombination (Figure S4C).
To test the effects of sTF on differentiation, we used an
(legend on next page)
Stem Cell Reports j Vol. 13 j 1–15 j December 10, 2019 5
Please cite this article in press as: Matjusaitis et al., Reprogramming of Fibroblasts to Oligodendrocyte Progenitor-like Cells Using CRISPR/
Cas9-Based Synthetic Transcription Factors, Stem Cell Reports (2019), https://doi.org/10.1016/j.stemcr.2019.10.010
Please cite this article in press as: Matjusaitis et al., Reprogramming of Fibroblasts to Oligodendrocyte Progenitor-like Cells Using CRISPR/
Cas9-Based Synthetic Transcription Factors, Stem Cell Reports (2019), https://doi.org/10.1016/j.stemcr.2019.10.0108-day two-step differentiation protocol (Figure 2D). Cells
acquired a typical OL morphology and were immunoposi-
tive for O4, A2B5, and NG2 (Figure 2E). A 2-fold increase
in a number of O4+ cells was observed in cells containing
sTFs (on average, 14.1% for parental cells versus 27.4%
for sTF-induced cells) (Figures 2F and 2G). Furthermore,
these cells had higher mRNA levels of various OL-related
genes such as Mbp, Ng2, Pdgfra, and s100b (Figure 2H).
There was no obvious difference between cell lines for
GFAP and TUJ1 staining after differentiation (Figure S4B).
Finally, BL6 S8 cells formed MBP+ myelin sheaths after in-
jection into the corpus callosum of shiverer MBPshi/shi
mice (Figure 2I). Thus, activation of Sox10 transcription
inNSCs using sTFs can increase the frequency ofOL lineage
specification and differentiation commitment.
Simultaneous Transcriptional Activation of
Endogenous Sox10, Olig2, and Nkx6-2 in MEFs Using a
Single Plasmid
We next explored whether sTFs could trigger reprogram-
ming of fibroblasts to OPCs. Previous studies have shown
that this is possible by viral cDNA overexpression of three
transcriptional regulators Sox10, Olig2, and Nkx6-2 or
Zfp536 (Najm et al., 2013; Yang et al., 2013). Activation
of Sox10 alone is therefore not sufficient for efficient re-
programming of fibroblasts to OPCs. We wished to extend
our sTF approach to enable activation of multiple genes us-
ing multiple gRNAs simultaneously in the same cell.
We first tested each gene individually to identify sTFs
that can activate target genes in MEFs. We designed ten
different gRNAs for each of the three promoters (Figure 3A)
and tested them individually by co-transfecting with
dCas9-VP160 (Figures 3B–3D). For Sox10 the same three
gRNAs (G—I) that were functional in NSCs were also effec-
tive in MEFs (Figure 3B). Ten gRNAs for Olig2 and Nkx6-2
were tested in MEFs (Figures 3C and 3D), as well as NSCs
(Figures S2A and S2B). For all three genes the most potent
gRNAs were located <300 bp upstream of TSS. Surprisingly,Figure 2. Effect of sTF-Based Sox10 Transcription Activation on N
(A) Plasmid S8 containing eight gRNAs targeting Sox10 and dCas9-VP1
(B) qRT-PCR data showing levels of Sox10 mRNA in BL6 S8 stable cell
(C) Western blot demonstrating SOX10 protein levels in BL6 and BL6
(D) Schematic summarizing the experimental strategy.
(E) Immunofluorescent images after O4, A2B5, and NG2 staining on d
(F) Example of flow cytometry data for O4 surface protein (oligodend
(G) Quantification of flow cytometry of three different differentiatio
p < 0.0001).
(H) qRT-PCR data of BL6 cells in self-renewal (‘‘BL6’’), differentiated BL
8 days of differentiation (n = 3; unpaired t test).
(I) Immunofluorescent images of MBP staining of Shiverer MBPshi/shi
P2 mice.
Statistical analysis—dots represent biological replicates, bars indica
Statistical significance is marked by asterisks (*). See also Figures S2
6 Stem Cell Reports j Vol. 13 j 1–15 j December 10, 2019the sTFs that activated Nkx6-2 in MEFs did not work in
NSCs (Figure S2B). This was not explained by the strength
of the activation domain, as no significant transcription
activation was observed even when VP160 was exchanged
with stronger effectors, such as VPR (Chavez et al., 2015)
and p300 (Hilton et al., 2015) (Figure S2C). This suggests
significant cell-type-dependent requirements for testing
and validating the sTFs.
Once again, we found that pools of gRNAs were more
effective than any single gRNA (Figures 3B–3D). Multiplex
delivery of combinations of two or three gRNAs gave the
highest and most consistent activation for Olig2 and
Nkx6-2, reaching similar levels to pools of all ten gRNAs
(Figure 3E). Thus, delivery of two or three gRNAs provides
a reliable approach to activating target genes of interest
in MEFs (Figure 3F). These validated gRNAs were built
into a single expression plasmid enabling simultaneous
multiplex activation of the three target genes (Figure 3G).
We constructed three different A1P vectors with increasing
numbers of gRNAs. The A1P-SON vector contained only
three gRNAs in total, one for each gene (Sox10, Olig2, and
Nkx6-2) (Figure 3G, blue bars); the A1P 2SON vector had
two gRNAs for Sox10 andOlig2 and a single forNkx6-2 (Fig-
ure 3G, violet bars); and, finally, the A1P 3SON vector had
three gRNAs for Sox10 andOlig2 and two gRNAs forNkx6-2
(Figure 3G, yellow bars). TwoNkx6-2 gRNAs were chosen as
this was sufficient to reach >100-fold activation in MEFs
(Figure 3E), thereby providing similar levels of activation
to Olig2 and Sox10.
Head-to-head comparisons of these three different plas-
mids confirmed that increasing the number of functional
gRNAs correlated with higher levels of target gene tran-
scriptional activation (as seen with Sox10 gene in partic-
ular). Strongest activation was observed using multiple
gRNAs: Sox10 from 2.7-fold change (1 sgRNA) to 141-fold
change (3 gRNAs); Olig2 from 24-fold (1 sgRNA) change
to 69-fold change (3 gRNAs); Nkx6-2 from 193-fold
(1 sgRNA) change to 197-fold change (2 gRNAs) (Figure 3G).eural Stem Cell Differentiation to Oligodendrocytes
60 was stably integrated into a wild-type BL6 NSC line (BL6 S8 NSC).
line 2 weeks after transfection (n = 3; unpaired t test p = 0.04).
S8 cell lines.
ifferentiated BL6 S8 NSC at day 9.
rocyte marker) of BL6 and BL6 S8 NSC at day 9.
n experiments as described in (C) (n = 3; ordinary one-way ANOVA
6 cells (‘‘BL6 OL’’), and differentiated BL6 S8 cells (‘‘BL6 S8 OL’’) after
mice brain section 21 days after BL6 S8 cells were transplanted into
te means; error bar represent SD; unpaired t tests were performed.
and S4.
(legend on next page)
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scription activation of all three factors to a similar extent
at mRNA (Figure 3G) and protein (Figure 3H) level, but
does not activate neighboring genes (Polr2f, Olig1, and
Cfap46) (Figure S2D).
Simultaneous Activation of Sox10, Olig2, and Nkx6-2
with sTFs Initiates Direct Reprogramming of Mouse
Fibroblasts to MBP-Expressing OL-like Cells
With the validated plasmids for multiplex activation of
Sox10, Olig2, and Nkx6-2 in hand, we next tested whether
delivery of the sTFs could drive MEF transdifferentiation
(TD) to OPCs. For this, we generated fresh primary MEFs
from distal limbs of E12.5 mouse embryos to avoid the
risk of contamination of spinal cord-derived NSCs or
OPCs. The resulting cultures displayed the typical MEF
morphology and by qRT-PCR did not express NSC and
OPC marker genes (Figures S5A and S5B). We stably co-
transfected MEFs and switched to TD medium 3 days later
(see Experimental Procedures for details of medium
composition). Immunocytochemistry, flow cytometry,
and qRT-PCR were used to score cells after 24 days
(Figure 4A).
MEFs were transfected with three plasmids: A1P-3SON
(containing eight gRNAs for Sox10, Olig2, and Nkx6-2),
A1P-S8 (containing eight gRNAs for Sox10), and CAG-
driven pBase transposase. From day 14 onward (peaking
at day 24) we noted cells undergoing morphological
changes resembling OPCs in the sTF-expressing cells, but
not in non-transfected MEF controls (Figure 4B). Impor-
tantly, we observed the emergence of O4+ cells in cells
transfected with sTFs (plasmids A1P-3SON and A1P-S8;
A1P-3SON alone was less efficient), while control MEFs
were negative for both markers (Figure 4C). QuantificationFigure 3. Sox10, Olig2, and Nkx6-2 Activation Using sTFs in Mous
(A) Schematic representation of the sgRNA target positions designed f
spanning the proximal promoters of Sox10, Olig2, and Nkx6-2 (400
gene).
(B–E) qRT-PCR results for Sox10, Olig2, and Nkx2-2 in MEF cells followin
(B) Sox10 targeted by single co-transfected gRNAs (A, B, C, etc.) co
ordinary one-way ANOVA p < 0.0001). (C) Olig2 targeted by single g
simultaneously (n = 3; ordinary one-way ANOVA p < 0.0001). (D) Nkx6-
gRNAs delivered simultaneously (n = 3; ordinary one-way ANOVA p <
combinations of two or three gRNAs, co-transfected with dCas9-VP160
control is transfection with dCas9-VP160 alone (No gRNAs).
(F) Immunofluorescent images for OLIG2 in non-transfected MEFs (‘‘Co
(‘‘sTFs’’).
(G) Graphical representation of three all-in-one plasmids (SON, 2SON, a
targeting Sox10, Olig2, and Nkx6-2 (top panel). qRT-PCR results for So
plasmids after 3 days (bottom panel) (n = 3; ordinary one-way ANOV
(H) Western blot demonstrating SOX10 and OLIG2 protein levels in M
Statistical analysis—dots represent biological replicates, bars indica
Statistical significance is marked by asterisks (*). See also Figure S2.
8 Stem Cell Reports j Vol. 13 j 1–15 j December 10, 2019confirmed sTF-expressing cells had on average 8.9% O4+
cells; controls (MEFs in MEF medium and MEFs in TD me-
dium) were <1% O4+ cells (Figure 4D).
Although we cannot quantify the efficiency of reprog-
ramming directly because of cell death and cell replication
during TD, in relative terms this efficiency is comparable
with previous reports using viral cDNA overexpression:
9.2% (Najm et al., 2013) and 15.6% (Yang et al., 2013) of
O4+ cells. If wewould be able to increase integration and/or
transfection efficiency (currently less than 1% and 30%,
respectively; Figure S5C) to that achieved with viral deliv-
ery in previous studies, reprogramming efficiency using
sTFs might surpass that of cDNA overexpression.
We harvested O4+ cells after 24 days using fluorescence-
activated cell sorting (FACS) and extracted mRNA for
qRT-PCR. This confirmed upregulation of many OL lineage
markers, such asMbp,Cspg4 (Ng2), andNkx2-2, and also the
expected Sox10, Olig2, and Nkx6-2 (Figure 4E). To check if
the reprogramming process gave raise to other astrocytes
or neuronal cells, we performed immunostaining for
TUJ1, GFAP, and NESTIN at day 24 (Figure S4A). Only a
few isolated TUJ1+ cells were observed in both conditions
(likely a remnant of peripheral neurons during MEF har-
vesting). Although we have identified some MBP+ cells,
these were infrequent in vitro, and therefore in vivo experi-
ments were performed next.
To test if the induced oligodendrocyte progenitor-like
cells (iOPCs) were able to integrate into mouse brain and
contribute to myelin formation we performed the
following experiments (Figure 5A). Firstly, we transdiffer-
entiated cells after transfecting them with either sTFs
(Ai1-3SON and Ai1-S8) and GFP-expressing plasmids
(‘‘With sTF’’) or just GFP-expressing plasmids (‘‘No sTF’’).
Twenty-one days after TD induction, we transplanted cellse Embryonic Fibroblasts
or transcriptional activation of Sox10, Olig2, and Nkx6-2. Ten gRNAs
to 50 bp from TSS) were tested (termed A through to J for each
g co-transfection with gRNAs and dCas9-VP160 after 3 days (n = 3).
mpared with a pool of 10 gRNAs delivered simultaneously (n = 3;
RNAs (A, B, C, etc.) compared with a pool of 10 gRNAs delivered
2 targeted by single gRNAs (A, B, C, etc.) compared with a pool of 10
0.0001). (E) Transcription activation comparison of pools of ten or
, targeting Sox10, Olig2, or Nkx6-2 (n = 3; unpaired t test). Negative
ntrol’’) and MEFs transfected with dCas9-VP160 and G-I Olig2 gRNAs
nd 3SON) containing dCas9-VP160 and increasing number of gRNAs
x10, Olig2, and Nkx2-2 in MEF cells following delivery of all-in-one
A p = 0.001).
EFs 3 days after transfection with A1P-3SON plasmid (‘‘3SON’’).
te means; error bar represent SD; unpaired t tests were performed.
(legend on next page)
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MBPshi/shi mice brain slices, cultured slices for another
10 days, and then stained for GFP and MBP (Figures 5C
and 5D). In P2 brain slices, we observed engrafted GFP+
cells with elaborate OL-like morphology, but they did not
express MBP. In adult shiverer MBPshi/shi mice brain slices
we observed partial colocalization ofMBP andGFP staining
(Figure 5D), suggesting that transdifferentiated cells can
engraft and differentiate to generate MBP+ sheaths, albeit
with lower frequency compared with NSC- or ESC-derived
OPCs (Figures 2I and S5D).
Next, we transplanted 5 3 105 transfected and TD me-
dium-induced cells (via a bilateral injection of 2.5 3 105
cells), or non-transfected but TD medium-induced MEFs
(negative control) into developing corpus callosum of P2
Shiverer (MBPshi/shi) mice (Figure 5E). We also tested
OPCs derived from ESC differentiations as a positive con-
trol (Figure S5D). Twenty-one days later, mice were
perfused, tissue was collected, and immunohistochemistry
for MBP and neurofilament (NF) was performed on coronal
brain sections to identify neurons (NF+) and MBP+ cells.
Indeed, we identified a number of MBP-expressing cells
near and around injection tracks in the mice that were
transplanted with induced OL (iOL) (Figure 5F), but not
in mice transplanted with control MEF cells (Figure S5E).
However, we did not observe myelin sheath formations
in iOL-transplanted mice, while ESC-derived OPCs were
able to form myelin sheaths (Figure S5D). These data sug-
gest that, while iOLs are able to engraft, and express O4
and MBP, they have some deficits that restrict their func-
tional maturation with regards to myelination.DISCUSSION
CRISPR/dCas9-based lineage programming and reprogram-
ming has been reported previously for various lineages, but
to our knowledge has not yet been explored in NSCs orFigure 4. MEF Transdifferentiation to Induced Oligodendrocytes
(A) Schematic summarizing the experimental strategy. MEFs were
(from Figure 3), and CAG-driven PiggyBac transposase. Three days late
incubated in transdifferentiation (TD) medium (see Experimental Pro
(B) Phase contrast images of non-transfected (‘‘No sTFs’’) and transfe
(C) Immunofluorescence images for O4 and MBP in non-transfected (N
TD medium, day 24.
(D) Typical example of flow cytometry data for O4+ cells in MEFs that h
transfected and cultured in TD medium (With sTFs), day 24. Quant
experiments (n = 5; ordinary one-way ANOVA p < 0.001).
(E) qRT-PCR results for various lineage-specific markers in either MEFs
transfected with sTFs and treated with TD medium and sorted for O4 s
unpaired t test).
Statistical analysis—dots represent biological replicates, bars indica
Statistical significance is marked by asterisks (*). See also Figure S5.
10 Stem Cell Reports j Vol. 13 j 1–15 j December 10, 2019fibroblasts for production of OLs. In this study we have
shown the power of these tools when delivered as a single
plasmid, to activate in multiplex several key master regula-
tors of OL lineage. These were used to enhance NSC differ-
entiation and MEF TD toward OLs. This study adds to a
growing body of evidence showing that CRISPR/dCas9
can be used in cell fate programming, potentially
improving on some more conventional methods such as
cDNA overexpression.
When performing initial gRNA functionality screens in
NSCs and MEFs, we found that only some of the sgRNAs
were functional individually. Pooling multiple gRNAs
(from 2 to 10) resulted in synergistic transcriptional activa-
tion. This is consistent with previous studies using sTFs—
both TAL effector and dCas9 based (Black et al., 2016;
Perez-Pinera et al., 2013). The most effective gRNAs we
identified were within 130 bp and 300 bp from the TSS.
One possible explanation for the synergy is that sTF bind-
ing/dissociation dynamics and, more importantly, tran-
scription co-factor recruitment probability is increased
due to increased number of sTFs around the accessible parts
of the promoter. Although Sox10 was amenable to activa-
tion in bothMEFs and NSCs,Nkx6-2 activation has worked
only in MEFs. Interestingly, we find that even stronger
effector domains, such as p300 or VPR, are not capable of
overcoming the unknown biological barriers. Thus, for re-
programming studies our data suggest that multiple sgRNA
need to be screened in the relevant host cell and potentially
used as a pool to drive reliable and high levels of target gene
expression.
We first tested sTFs in NSC differentiation context and
demonstrated that Sox10 activation alone can enhance
NSC differentiation toward OPCs. A total of 15%–20% of
differentiating NSCs (control) becomeOPCs. After we engi-
neered these cells to express sTFs targeting Sox10 for tran-
scriptional activation, we recorded over 73% of OPCs after
4 days of differentiation. In comparison, overexpression of
SOX10 gave on average 52% of OPCs. A similar trend ofafter sTF-Mediated Activation of Sox10, Olig2, and Nkx6-2
co-transfected with three plasmids, S8 (from Figure 2), 3SON
r, transfected (‘‘With sTF’’) and non-transfected MEFs (‘‘No sTF’’) were
cedures for details).
cted MEFs (‘‘With sTFs’’) 24 days after transfection.
o sTFs) and transfected (With sTFs) MEFs that have been cultured in
ave been cultured in TD medium (No sTFs) and MEFs that have been
ification of flow cytometry data from 5 separate reprogramming
(black), MEFs treated with OPC-permissive media (blue), and MEFs
urface marker (green) at the end of a 24-day-long protocol (n = 2;
te means; error bar represent SD; unpaired t-tests were performed.
Figure 5. Transplantation of Reprogrammed iOLs to P2 or Adult Shiverer (MBPshi/shi) Mice or Mice Brain Slices
(A) Schematic summarizing the experimental strategy. Transfected and transdifferentiated MEFs were transplanted into Shiverermice brain
slices. Ten days after transplantations brain tissue section were stained.
(B) qRT-PCR results for Sox10, Olig2, and Nkx6-2 in sTF-transfected cells before the transplantation (n = 2; unpaired t test).
(C) Immunohistochemistry for GFP in P2 Shiverer (MBPshi/shi) mice brain slices that were transplanted with cells transfected with sTF and
GFP (With sTF) or just GFP (No sTF).
(legend continued on next page)
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line. Although a significant enhancement of differenti-
ating NSCs was achieved it was not a uniform response,
suggesting further barriers to steering differentiation paths.
It will now be interesting to investigate if activating a larger
number of OPC/OL-specific genes, and/or repressing some
NSC fate modulators (e.g., SOX2), would result in even
more efficient or more rapid differentiation process.
To test if MEF TD could be initiated by sTFs, we needed
activation of multiple genes with multiple sgRNAs and
therefore we developed an improved plasmid-based strat-
egy. This modular system is based on Golden Gate
assembly, and allowed contruction of A1P, containing: Pig-
gyBac ITR sequences, dCas9-VP160 (or other types of
effector) and up to eight U6-sgRNA subunits. This provides
a simple, yet flexible, system. Use of the piggyBac provides
a means to generate stable genomic integration of the
cassette with a possibility of excision if required (Wang
et al., 2008). Although transfection-based delivery of piggy-
Bac-based plasmids is less efficient compared with trans-
duction-based lentivirus, lentivirus-based delivery is
limited by restrictions to cargo size (maximum ±11 kb)
and requires time-consuming and expensive viral produc-
tion. To compensate for lower transfection/integration effi-
ciencies of PiggyBac system it is possible to select positive
cells via reporter gene inclusion. Although positive selec-
tion (using FACS or antibiotics) might be difficult for pri-
mary cells with lower replicative capacity, for those reprog-
ramming experiments using proliferative starting cells
(e.g., fibroblasts) the PiggyBac approach will be useful.
As ESC/iPSC differentiation relies on recapitulating the
events that happened in an early embryo development,
in vitro protocol that mimic these processes are inherently
slow. The ultimate goal of CRISPR/dCas9 in cell fate reprog-
ramming is to efficiently drive cell reprogramming in a reli-
able and rapid manner. One alternative to a cumbersome
iPSC dedifferentiation-differentiation regime is direct cell
fate programming (or TD) fromone somatic cell to another.
We demonstrated that TD can be initiated by activating
multiple genes using two non-viral plasmids each contain-
ing dCas9-VP160 and eightU6-sgRNA subunits. The activa-
tion of three master regulator genes—Sox10, Olig2, and
Nkx6-2—in MEFs using A1Ps provided 9% conversion
to OL-like cells. These cells were positive for O4, key(D) Immunohistochemistry for GFP and MBP in adult Shiverer (MBPshi
with sTF and GFP (With sTF).
(E) Schematic summarizing the experimental strategy. Transfected an
P2. Twenty-one days after transplantations, mice were perfused, coron
(F) Immunohistochemistry for MBP and NF in Shiverer (MBPshi/shi) P2
with sTF and GFP.
Statistical analysis—dots represent biological replicates, bars indica
Statistical significance is marked by asterisks (*). See also Figure S5.
12 Stem Cell Reports j Vol. 13 j 1–15 j December 10, 2019markers of OPC lineage. Furthermore, we observed that
once transplanted these reprogrammed OPCs were able
to integrate into P2 or adult Shiverer (MBPshi/shi) mouse
brain in vivo and in vitro, and express MBP—a known
marker for mature myelinating OLs. However, in all myeli-
nation assays we could only observe a few MBP+ cells and/
or sheaths. This suggests that final maturation stage is
incomplete in these reprogrammed cells. We believe that
there could be a technical and/or biological explanation.
Technically, maturation might be enhanced if cells were
enriched for O4+/OPC cells after TD and before transplan-
tations. MBP cells seem to tightly surround reprog-
rammed MBP+ cells, possibly preventing their interaction
with NF+ neurons (Figure 5F). Biologically, it might be
also important to lower expression of some or all of the
initial transcription factors (Sox10, Olig2, and Nkx6-2) to
allow cells to reachmaturation effectively. Currently, levels
of transcripts remained high in transdifferentiated cells just
before transplanting them (Figure 5B). Future studies and
genome-wide transcriptional and epigenetic profiling in
single cells will help define the roadblocks.
In future studies it will be interesting to push further the
scale of multiplexing—perhaps activating transcription of
tens or hundreds of genes at the same time—as this might
be a key advantage of sTFs over more traditional ectopic
overexpression methods in redirecting cell identity.
Human artificial chromosomes could be used to deliver
hundreds of sgRNAs and different versions of dCas9 into
a single cell, allowing unprecedented multiplexing capac-
ity (Martella et al., 2016). As the toolkit of CRISPR/Cas
effectors expands it is likely that current sTF multiplexing
capabilities will be expanded further by combining activa-
tors and repressors with chromatin editors. It will also be
interesting to explore richer microenvironmental cues,
such as scaffolds, or mechanical forces, which could help
stimulate improved reprogramming and differentiation.
In conclusion, we have demonstrated sTF-mediated NSC
directed differentiation aswell as initiation of direct reprog-
ramming ofMEFs intoOL-like cells.We have achieved such
reprogramming events using a viral-free delivery strategy
that enables activation of three separate genes inmultiplex
using up to eight sgRNA units. These sTFs clearly provide
remarkable new tools that enable fundamental studies of
reprogramming mechanisms and the transcriptional and/shi) mice brain slices that were transplanted with cells transfected
d transdifferentiated MEFs were transplanted into Shiverer mice at
al brain tissue sections were collected and staining was performed.
mice coronal brain slices of mice transplanted with cells transfected
te means; error bar represent SD; unpaired t tests were performed.
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improved knowledge of the core transcriptional circuits
and epigenetic programs that define each cell type and
cell state, the in vivo resetting ofmammalian cell-type iden-
tity using sTFs will likely drive considerable advances in
regenerative medicine.EXPERIMENTAL PROCEDURES
NSC Differentiation
NSCswere triggered to differentiate toOPCs using following differ-
entiation protocols (Pollard, 2013). A day before differentiation,
the cells were seeded at 2 3 104 cells per well of a 6-well plate.
The next day, fresh culture medium lacking EGF but containing
10 mM Forskolin (Cambridge BioScience, no. 11018), 10 ng/mL
PDGF-AA (R&D System, no. 221-AA-010) and FGF-2 (10 ng/mL)
was added. Cells were left in such differentiation medium for
4 days, and then analyzed or induced to differentiate to OLs using
the medium described below.
To differentiate OPCs to OLs, NSC culture medium lacking EGF
and FGF, but containing 5% fetal calf serum (FCS) was used.
MEF TD Growth Medium and Protocol
MEFs were transdifferentiated to OPCs using the following proto-
col: cells were transfected (see below) and left in MEF culture me-
dium for 3 days. After 3 days, the MEF culture medium was
exchanged with MEF TD medium. TD medium contained the
following DMEM/F12 (Invitrogen, no. 11320) supplemented
with 1:100 N-2 (Life Technologies, no. 17502-048), 1:50 B-27
(Life Technologies, no. 17504-044), 2 mM GlutaMAX (Life Tech-
nologies, no. A1286001), 200 ng/mL SHH (R&D Systems, no.
461-SH-025/CF), 20 ng/mL FGF2 (R&D Systems), 20 ng/mL
PDGF-AA (R&D Systems, no. 221-AA-010), and 2 mg/mL Laminin
(Sigma).
To drive transdifferentiating MEFs to differentiate to MBP+ OL,
21 days after transfection TD cells were incubated in the following
medium for 3 days: DMEM/F12 (Invitrogen, no. 11320) supple-
mented 1:100 N-2 (Life Technologies, no. 17502-048), 1:50 B-27
(Life Technologies, no. 17504-044), 2 mM GlutaMAX (Life Tech-
nologies, no. A1286001), 40 ng/mL T3 (Sigma), 200 ng/mL SHH
(R&D Systems, no. 461-SH-025/CF), 100 ng/mL Noggin (R&D Sys-
tems, no. 3344-NG-050), 50 mM cAMP (Sigma, no. D0260-5MG),
100 ng/mL IGF (R&D Systems, no. 291-G1-200), 10 ng/mL NT3
(R&D Systems, no. 267-N3-005/CF). This is based on the protocol
previously published by Najm et al. (2013).
Immunofluorescence
Cells were washed with PBS and fixed with 4% paraformaldehyde
(PFA) for 10 min at room temperature. After fixation, cells were
washed three times with PBS. Cells were then blocked at least
for 1 h in blocking solution (1% BSA, 3% goat serum, 0.1% Triton
in PBS, unless stated otherwise). The blocking solution was
removed and the primary antibody (anti-OLIG2 1:400, EMD
Millipore, catalog no. 2367; anti-O4 1:200, Immunosolv [product
discontinued]; anti-MBP 1:250, Bio-Rad, catalog no. MCA409S;
anti-SOX2 1:100, Sigma, catalog no. S9072; anti-SOX9 1:100,EMD Milipore, catalog no. AB5535; anti-GFAP 1:1,000, Sigma,
catalog no. G9269; anti-NESTIN 1:10, DSHB Hybridoma, catalog
no. rat-401; anti-TUJ1 1:500, BioLegend, catalog no. 801202;
anti-A2B5 1:100, Abcam, catalog no. ab53521) was added and
incubated at 4C overnight in blocking solution. After staining
with primary antibody, cells were washed three times with
PBST for 15 min. Cells were then stained with an appropriate sec-
ondary antibody (Alexa Fluor range; 1:1,000 dilutions) for at least
1 h in the dark at room temperature. Cells were washed two times
with PBS, stained with DAPI (1:5,000 in PBS) for at least 5 min
and washed with PBS twice.Flow Cytometry
Cells were analyzed using an LSRFortessa 5- or 4-laser flow cytom-
eter (BD Biosciences). Unless stated otherwise, 10,000 events
were collected using forward scatter threshold of 5,000. Fluores-
cence data were collected using following cytometer settings:
488 nm laser and B530/30-A nm bandpass filter for GFP/
NeoGreen, 561 nm laser and YG586/15-A nm bandpass filter
for mRuby2/mCherry, 405 nm laser and V450/50-A nm bandpass
filter for DAPI. DAPI staining was used to separate live and dead
cells in every experiment. Data were analyzed using the FlowJo
software.
When cell surface markers were assessed (O4), we immuno-
stained live cells using the following protocol: cells were lifted
with Accutase and incubated with PBS containing 1:200 Fc block
CD16/CD32 (BD Pharmingen, no. 553141). Cells were left for
30 min at room temperature. After incubation, the cells were
washed with 2% FCS/PBS and incubated with appropriately
diluted (in 2% FCS/PBS) primary anti-O2 antibody (Immunosolv).
Cells were left for 30 min at room temperature. After incubation,
the cells were washed with 2% FCS/PBS and incubated with appro-
priately diluted (in 2% FCS/PBS) secondary antibody (Alexa Fluor
range; 1:1,000). Cells were left for 30 min at room temperature
in dark. After incubation, cells were washed with 2% FCS/PBS
and analyzed with the flow cytometer.In VitroMyelination Assay with Shiverer Brain Slices
Slices were prepared essentially as described previously (Marque´s-
Torrejo´n et al., 2017). Postnatal day 2 or adult Shiverer mice were
sacrificed and whole brains were embedded in agarose. Coronal
brain slices (300 mm) were cut using a Vibratome (Leica). These
were cultured for 3 days on a semi-permeable membrane cell cul-
ture insert (Millipore) using the followingmedium: 50%minimum
essential medium a, 25%Hank’s balanced salt solution, 25% horse
serum, 6.5 mg/mL glucose, 2 mM glutamine, 1% N2 supplement,
1% P/S, 60 ng/mL T3, 25 mg/mL insulin, 20 mg/mL ascorbic acid,
and 1 mM cAMP. After 3 days in cell culture, 2–4 mL of cell suspen-
sion (53 104 cells) was injected into brain slice. Slices were left for
another 10 days to allow injected cell integration. Brain slices
were then fixed with 4% PFA, washed with PBS, and stained
with primary antibodies (anti-MBP 1:250, Bio-Rad, catalog no.
MCA409S) for 2 days. Slices then were washed three times with
PBS and stained with appropriate secondary antibody (Alexa Fluor
range, 1:1,000) and DAPI for 4–6 h. Slices were washed with PBS
and placed on glass slides. FluorSave (Milipore, no. 345789) was
used to prevent photobleaching.Stem Cell Reports j Vol. 13 j 1–15 j December 10, 2019 13
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All animal experiments were performed in line with UK Home Of-
fice guidelines. Under isoflurane anesthesia, P2 ShivererMBPshi/shi
mice received intracranial injection of 5 3 105 cells (via a bilateral
injection of 2.5 3 105 cells) into the developing corpus callosum.
MEFs, induced OPCs, or a positive control of mouse OPCs gener-
ated from ESCs were injected. Mice were perfused 21 days after in-
jection. Tissue was collected and fixed in 4% PFA. Coronal sections
(10 mm) were collected and blocked with 0.1% Triton X-100
(Sigma), 10% horse serum (Life Technologies) in PBS. Sections
were incubated overnight at 4C with rat anti-MBP (1:250, Bio-
Rad, catalog no. MCA409S) followed by 1 h incubation with Alexa
Fluor 568 goat anti-rat (1:1,000, Life Technologies, catalog no.
A11077) and Hoechst (1:2,000, Thermo Fischer Scientific, catalog
no. 62249). Slides were mounted and imaged on a Zeiss observer
Z1. Images were processed using Zen software and ImageJ.SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2019.10.010.
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